Search research articles
Contact Us
Filters
Showing results (1-10 of 16) with videos related to
Page
of 2
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 27, 2015
Molecular Pathways: Increased Susceptibility to Infection Is a Complication of mTOR Inhibitor Use in Cancer Therapy
Adrian M Eiden, Shuling Zhang, Joy M Gary, et al.
Mammalian Genome : Official Journal of the International Mammalian Genome Society
|
February 24, 2012
Mouse genetics 2011: meeting report
John K Simmons, Jessica C Amlin-Van Schaick, Thomas R Geiger, et al.
Journal of Cancer Metastasis and Treatment
|
September 14, 2020
Mouse tumor susceptibility genes identify drug combinations for multiple myeloma
Shuling Zhang, Wendy DuBois, Ke Zhang, et al.
ACS Chemical Biology
|
October 15, 2015
Small Molecule Microarrays Enable the Identification of a Selective, Quadruplex-Binding Inhibitor of MYC Expression
Kenneth M Felsenstein, Lindsey B Saunders, John K Simmons, et al.
Journal for Immunotherapy of Cancer
|
March 30, 2020
Characterization of tumor mutation burden, PD-L1 and DNA repair genes to assess relationship to immune checkpoint inhibitors response in metastatic renal cell carcinoma
Matthew Kyle Labriola, Jason Zhu, Rajan T Gupta, et al.
Molecular Oncology
|
January 17, 2014
TORC1 and class I HDAC inhibitors synergize to suppress mature B cell neoplasms
John K Simmons, Jyoti Patel, Aleksandra Michalowski, et al.
Scientific Data
|
April 19, 2025
Large-scale human myeloma cell line small molecule compound screen dataset
V Keith Hughitt, John K Simmons, Sayeh Gorjifard, et al.
Cancer Letters
|
September 7, 2014
Loss-of-function RNAi screens in breast cancer cells identify AURKB, PLK1, PIK3R1, MAPK12, PRKD2, and PTK6 as sensitizing targets of rapamycin activity
Oliver Ou, Konrad Huppi, Sirisha Chakka, et al.
Nature Communications
|
October 14, 2018
Chemical and structural studies provide a mechanistic basis for recognition of the MYC G-quadruplex
David R Calabrese, Xiang Chen, Elena C Leon, et al.
Molecular Cancer Therapeutics
|
May 20, 2017
Cooperative Targets of Combined mTOR/HDAC Inhibition Promote MYC Degradation
John K Simmons, Aleksandra M Michalowski, Benjamin J Gamache, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 16) with videos related to
Sort By:
Page
of 2
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 27, 2015
Molecular Pathways: Increased Susceptibility to Infection Is a Complication of mTOR Inhibitor Use in Cancer Therapy
Adrian M Eiden, Shuling Zhang, Joy M Gary, et al.
Mammalian Genome : Official Journal of the International Mammalian Genome Society
|
February 24, 2012
Mouse genetics 2011: meeting report
John K Simmons, Jessica C Amlin-Van Schaick, Thomas R Geiger, et al.
Journal of Cancer Metastasis and Treatment
|
September 14, 2020
Mouse tumor susceptibility genes identify drug combinations for multiple myeloma
Shuling Zhang, Wendy DuBois, Ke Zhang, et al.
ACS Chemical Biology
|
October 15, 2015
Small Molecule Microarrays Enable the Identification of a Selective, Quadruplex-Binding Inhibitor of MYC Expression
Kenneth M Felsenstein, Lindsey B Saunders, John K Simmons, et al.
Journal for Immunotherapy of Cancer
|
March 30, 2020
Characterization of tumor mutation burden, PD-L1 and DNA repair genes to assess relationship to immune checkpoint inhibitors response in metastatic renal cell carcinoma
Matthew Kyle Labriola, Jason Zhu, Rajan T Gupta, et al.
Molecular Oncology
|
January 17, 2014
TORC1 and class I HDAC inhibitors synergize to suppress mature B cell neoplasms
John K Simmons, Jyoti Patel, Aleksandra Michalowski, et al.
Scientific Data
|
April 19, 2025
Large-scale human myeloma cell line small molecule compound screen dataset
V Keith Hughitt, John K Simmons, Sayeh Gorjifard, et al.
Cancer Letters
|
September 7, 2014
Loss-of-function RNAi screens in breast cancer cells identify AURKB, PLK1, PIK3R1, MAPK12, PRKD2, and PTK6 as sensitizing targets of rapamycin activity
Oliver Ou, Konrad Huppi, Sirisha Chakka, et al.
Nature Communications
|
October 14, 2018
Chemical and structural studies provide a mechanistic basis for recognition of the MYC G-quadruplex
David R Calabrese, Xiang Chen, Elena C Leon, et al.
Molecular Cancer Therapeutics
|
May 20, 2017
Cooperative Targets of Combined mTOR/HDAC Inhibition Promote MYC Degradation
John K Simmons, Aleksandra M Michalowski, Benjamin J Gamache, et al.
Page
of 2